SEROQUEL Facts

  • SEROQUEL is approved by the US Food and Drug Administration (FDA) for depressive episodes in bipolar disorder in adults; manic episodes in bipolar disorder in adults when used alone or with lithium or divalproex; manic episodes in bipolar disorder in children and adolescents ages 10 to 17 years; long-term treatment of bipolar disorder in adults with lithium or divalproex; schizophrenia in adults; and schizophrenia in adolescents ages 13-17 years

  • SEROQUEL is a mood-stabilizing medication in the “atypical antipsychotic” class

  • While SEROQUEL treats symptoms of these disorders, there is no cure for bipolar disorder or schizophrenia

SEROQUEL Facts was developed to provide information about the potential side effects and benefits of treatment with SEROQUEL, and to describe the history surrounding this medicine. The information on this Web site should not take the place of patients talking with their doctor or health care professional about how to manage and treat bipolar disorder and schizophrenia.

What is SEROQUEL?

All medicines are divided into families or classes. SEROQUEL is a medicine within the "antipsychotic" class, a group of medicines that has been around since the 1950s. Within the antipsychotic class, there are newer medicines called atypical (or second generation) antipsychotics that were introduced starting in the 1990s. SEROQUEL is one of these atypical antipsychotic medicines, and has been FDA-approved for more than 10 years for the treatment of schizophrenia in adults. In 2004, the FDA approved SEROQUEL for the acute (or short-term) treatment of bipolar mania in adults and later, in 2006, approved it for the acute treatment of bipolar depression in adults. In 2008, SEROQUEL was approved as long-term treatment of bipolar disorder in adults with lithium or divalproex. In 2009, SEROQUEL was approved to treat schizophrenia in adolescents ages 13- 17 years and approved for manic episodes in bipolar disorder in children and adolescents ages 10 to 17 years.

How SEROQUEL Works

Chemical imbalances in the brain are believed to lead to the symptoms presented in bipolar disorder and schizophrenia. At this time, experts are not clear on what causes these chemical imbalances.

Although the exact way medicines like SEROQUEL work is unknown, they are thought to regulate the balance of certain chemicals in the brain. While SEROQUEL treats the symptoms of these disorders, it is important to note there is no cure for bipolar disorder or schizophrenia.

Learn More About SEROQUEL:

What SEROQUEL Does

SEROQUEL is FDA-approved to treat two serious mental illnesses, schizophrenia and bipolar disorder. Explore this section to learn more about what SEROQUEL does.

SEROQUEL Side Effects

Explore this section to learn more about potential side effects of taking SEROQUEL.

Regulation and Commitment to Patient Safety

SEROQUEL has been on the market for over 10 years and has been prescribed to millions of patients in the US. SEROQUEL is approved for the treatment of bipolar disorder and schizophrenia. Explore this section to learn about the regulatory history of SEROQUEL and the commitment of AstraZeneca to patient safety.

Research

AstraZeneca is committed to meeting patient health needs through innovative medicines and clinical excellence. AstraZeneca conducts clinical trials to help determine the safety and efficacy of our medicines and we monitor the safety of our products, including SEROQUEL. Explore this section to learn about research on SEROQUEL.

Contacting AstraZeneca

For SEROQUEL info:

1-800-236-9933
E-mail

For Media contact only:

Kirsten Evraire
E-mail
302-885-0435

Laura Woodin
E-mail
302-885-1087